Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

H1N1 vaccine safety monitoring: beyond background rates.

Destefano F, Tokars J.

Lancet. 2010 Apr 3;375(9721):1146-7. doi: 10.1016/S0140-6736(09)61917-6. Epub 2009 Oct 31. No abstract available.

PMID:
19880171
2.

Guillain-Barré syndrome and H1N1 influenza vaccine in UK children.

Verity C, Stellitano L, Winstone AM, Andrews N, Stowe J, Miller E.

Lancet. 2011 Oct 29;378(9802):1545-6. doi: 10.1016/S0140-6736(11)61665-6. No abstract available.

PMID:
22035553
3.

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.

Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N; H1N1 GBS Meta-Analysis Working Group.

Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8. Epub 2013 Mar 13.

PMID:
23498095
4.

Guillain-Barré syndrome after H1N1 influenza: a concern.

Wiwanitkit V.

Neuroepidemiology. 2013;40(4):295. doi: 10.1159/000346274. Epub 2013 Mar 13. No abstract available.

5.

Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Dec 11;58(48):1351-6.

6.

Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).

Souayah N, Yacoub HA, Khan HM, Michas-Martin PA, Menkes DL, Maybodi L, Qureshi AI.

Neuroepidemiology. 2012;38(4):227-32. doi: 10.1159/000336113. Epub 2012 Apr 27.

7.

Influenza vaccine and Guillain-Barré syndrome: making informed decisions.

Poland GA, Poland CM, Howe CL.

Lancet. 2013 Apr 27;381(9876):1437-9. doi: 10.1016/S0140-6736(13)60182-8. No abstract available.

PMID:
23622271
8.

[Safety and effectiveness of the influenza vaccine: new data, new challenges].

Trilla A.

Med Clin (Barc). 2013 Jul 21;141(2):67-9. doi: 10.1016/j.medcli.2013.04.011. Epub 2013 Jun 12. Spanish. No abstract available.

PMID:
23768850
9.

Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.

Salmon DA, Akhtar A, Mergler MJ, Vannice KS, Izurieta H, Ball R, Lee GM, Vellozzi C, Garman P, Cunningham F, Gellin B, Koh H, Lurie N; H1N1 Working Group of Federal Immunization Safety Task Force.

Pediatrics. 2011 May;127 Suppl 1:S78-86. doi: 10.1542/peds.2010-1722L. Epub 2011 Apr 18. Review.

PMID:
21502251
10.

Guillain-Barré syndrome associated with H1N1 vaccination.

Marin LF, Abrahão A, Carvalho FA, Santos WA, Dallalba CC, Barcelos LB, Silva GS, Oliveira AS.

Arq Neuropsiquiatr. 2010 Dec;68(6):974-5. No abstract available. Erratum in: Arq Neuropsiquiatr. 2011 Feb;69(1):147. Abrahão, Ayessandro [corrected to Abrahão, Agessandro].

11.

[Research progress of influenza type A(H1N1) vaccine and monitoring adverse reaction].

Zhang WW, Li L, Zhu FC.

Zhongguo Yi Miao He Mian Yi. 2010 Jun;16(3):275-8. Review. Chinese.

PMID:
20726275
12.
13.

Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.

Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, Ji W, Suo L, Liu D, Ma R, Yu R, Zhangzhu J, Liu W, Zeng Y, Li X, Zhang X, Pang X, Deng Y.

N Engl J Med. 2010 Dec 16;363(25):2416-23. doi: 10.1056/NEJMoa1006736.

14.

Pandemic (H1N1) 2009 influenza.

Polkinghorne B, Ward K, Totaro R.

N S W Public Health Bull. 2010 Jan-Feb;21(1-2):41-2. doi: 10.1071/NB09031. No abstract available.

15.

Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan.

Huang WT, Chen WW, Yang HW, Chen WC, Chao YN, Huang YW, Chuang JH, Kuo HS.

Vaccine. 2010 Oct 18;28(44):7161-6. doi: 10.1016/j.vaccine.2010.08.069. Epub 2010 Sep 15.

PMID:
20804804
16.

Monitoring the safety of pandemic H1N1 vaccine.

Huang WT, Chuang JH, Kuo SH.

Lancet. 2010 Apr 3;375(9721):1164. doi: 10.1016/S0140-6736(10)60515-6. No abstract available.

PMID:
20362814
17.

Pandemic influenza: a priority for the neurological community.

[No authors listed]

Lancet Neurol. 2009 Oct;8(10):869. doi: 10.1016/S1474-4422(09)70242-X. No abstract available.

PMID:
19747645
18.

Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.

Polakowski LL, Sandhu SK, Martin DB, Ball R, Macurdy TE, Franks RL, Gibbs JM, Kropp GF, Avagyan A, Kelman JA, Worrall CM, Sun G, Kliman RE, Burwen DR.

Am J Epidemiol. 2013 Sep 15;178(6):962-73. doi: 10.1093/aje/kwt051. Epub 2013 May 6.

PMID:
23652165
19.

Adverse effects following pandemic influenza (H1N1) 2009 vaccination.

Bolam B, Grills N.

Aust N Z J Public Health. 2009 Dec;33(6):584. doi: 10.1111/j.1753-6405.2009.00458.x. No abstract available.

PMID:
20078579
20.

[Guillain-Barré syndrome secondary to H1N1 influenza vaccine].

López Nieto M, Gómez Garrido J, Losa Palacios A, Aguila Manso G.

Rev Clin Esp. 2010 Oct;210(9):485-6. doi: 10.1016/j.rce.2010.05.003. Epub 2010 Sep 15. Review. Spanish. No abstract available.

PMID:
20832792

Supplemental Content

Support Center